A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F

Bone Marrow Transplant. 2016 Mar;51(3):451-3. doi: 10.1038/bmt.2015.268. Epub 2015 Nov 9.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Allografts
  • Antilymphocyte Serum / administration & dosage*
  • Antilymphocyte Serum / adverse effects
  • Bone Marrow Transplantation*
  • Busulfan / administration & dosage*
  • Busulfan / adverse effects
  • Chronic Disease
  • Female
  • Graft vs Host Disease / prevention & control*
  • Hematologic Neoplasms / therapy*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Prospective Studies
  • Transplantation Conditioning*
  • Unrelated Donors*
  • Vidarabine / administration & dosage
  • Vidarabine / adverse effects
  • Vidarabine / analogs & derivatives*

Substances

  • Antilymphocyte Serum
  • Vidarabine
  • Busulfan
  • fludarabine